MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    A phase 2b randomized, double-blind, placebo-controlled study of suvecaltamide in the treatment of adults with moderate to severe essential tremor: study design and methodology

    A. Sterkel, W. Ondo, R. Elble, P. Lewitt, R. Pahwa, C. Urrea, L. Huang, L. Hickey, M. Baladi (Palo Alto, USA)

    Objective: Evaluate the efficacy and safety of JZP385 (formerly CX-8998), a highly selective T-type calcium channel modulator, for symptomatic control of moderate to severe essential…
  • MDS Virtual Congress 2021

    Both online and in-person JOBGRIP group training for people with Parkinson’s with paid employment is acceptable and perceived to be valuable

    I. Sturkenboom, J. Vanomme-Vanlaarhoven, M. Noordegraaf, B. Bloem (Nijmegen, Netherlands)

    Objective: Explore acceptability and perceived efficacy of a group intervention for people with Parkinson’s diseases (PD) with paid employment. Background: PD leads to changes in…
  • MDS Virtual Congress 2021

    Autosomal recessive spinocerebellar ataxia type 10: a case report in Mexico

    D. Gasca Saldaña, D. Dávila Ortiz, N. Monroy Jaramillo, C. Aláez-Verson, L. Flores-Lagunes, P. Zamora Alaniz, C. Dehesa Caballero, C. Fresno Rodríguez, G. Vega-Rosas, M. Boll (Mexico City, Mexico)

    Objective: To provide a comprehensive description of the first clinical case of SCAR10 diagnosed in Mexico. Background: The autosomal recessive spinocerebellar ataxia type 10 is…
  • MDS Virtual Congress 2021

    NON-STRUCTURAL HEMICHOREA: REPORT OF NINE CASES

    B. Charra, V. Kurtz, J. Prez, G. Lopez, E. Garino, D. Ballesteros (Buenos Aires, Argentina)

    Objective: To analyze the etiology and clinical characteristics of patients with non-structural hemichorea treated in two neurology departments. Background: Hemichorea was classically associated with contralateral…
  • MDS Virtual Congress 2021

    Absence of neutralizing antibody formation during incobotulinumtoxinA treatment of spasticity in botulinum toxin-naïve children with cerebral palsy: pooled analysis of Phase 3 studies

    H. Chambers, P. Kaňovský, A. Schroeder, E. Dabrowski, T. Geister, A. Hanschmann, I. Pulte, M. Althaus, M. Banach, D. Gaebler-Spira, F. Heinen (San Diego, USA)

    Objective: To investigate neutralizing antibody (NAb) formation in three large Phase 3 studies with incobotulinumtoxinA, a botulinum neurotoxin type A (BoNT-A) with no complexing proteins,…
  • MDS Virtual Congress 2021

    Fatal Psychosis in a young Girl

    D. Joshi, M. Tapadia, K. Bismaya, A. Kumar (Varanasi, India)

    Objective: We describe a 24-year young female who presented to us with features of Neurolept malignant syndrome.  She was later evaluated and found to have…
  • MDS Virtual Congress 2021

    Current perspectives on the management of cervical dystonia among global clinicians

    H. Jinnah, H. Ferraz, S. Standal, P. Fattahi, A. Zuzek, N. Alibhai, K. Merath (Atlanta, USA)

    Objective: The aim of this study was to gain the perspectives of clinicians who treat patients with CD in terms of assessment and treatment goals,…
  • MDS Virtual Congress 2021

    Dystonia gravidarum: An emerging clinical entity

    E. Donlon, P. Moloney, S. Smyth, S. Lyons, T. Lynch, E. Mcgovern (Limerick, Ireland)

    Objective: We describe a case of cervical dystonia in a 36 year-old, secundigravid, Caucasian woman at 8 weeks gestation. Background: Though uncommon, primary movement disorders…
  • MDS Virtual Congress 2021

    Diagnosis and management of Myoclonus Dystonia Syndrome: a Survey of the European Reference Network for Rare Neurological Diseases.

    M. Vanegas, E. Timmers, F. Hamami, S. Boesch, W. Vandenberghe, O. Burgazlieva, M. Møller, L. Hjermind, M. Vidailhet, A. Meneret, T. Bäumer, S. Siegert, T. Gasser, L. Schoels, J. Molnar, A. Capuano, F. Nicita, G. Zorzi, A. Albanese, A. Federico, E. Lohmann, J. Guk, M. Willemsen, N. Wolf, M. Dec-Cwiek, D. Neubauer, D. Flisar, V. Gonzalez, A. Darling, M. Marti, H. Houlden, C. Reinhard, A. Weissbach, M. Tijssen, B. Perez-Dueñas (Barcelona, Spain)

    Objective: To evaluate the diagnostic and treatment strategies in Myoclonus Dystonia Syndrome (MDS) used by experts from the European Reference Network for rare neurological diseases…
  • MDS Virtual Congress 2021

    Neural Signals in the Cerebellar Nuclei Gate the Manifestation of Dystonia-Associated Symptoms in Mice

    M. Vander Heijden, T. Lin, D. Kizek, A. Brown, R. Sillitoe (Houston, USA)

    Objective: Define the differences in electrophysiological signatures of cerebellar output between mouse models of dystonia with diverse severity and manifestation. Background: Dystonia is heterogeneous movement…
  • « Previous Page
  • 1
  • …
  • 24
  • 25
  • 26
  • 27
  • 28
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • DaTscan in clinical evaluation of Multiple System Atrophy
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley